Literature DB >> 324625

Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.

H D Preisler, S Bjornsson, E S Henderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 324625

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

1.  Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease.

Authors:  S O Lie; K K Lie; A Glomstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Short-term treatment for acute myelogenous leukaemia.

Authors:  R Bell; A Z Rohatiner; M L Slevin; J M Ford; H S Dhaliwal; G Henry; B G Birkhead; J A Amess; J S Malpas; T A Lister
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-24

Review 3.  Advances in the management of adult acute myelogenous leukaemia.

Authors:  J A Whittaker
Journal:  Br Med J       Date:  1980-10-11

4.  Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.

Authors:  S Seeber; H Loth
Journal:  Blut       Date:  1981-06

5.  Uptake of adriamycin by human leukemic cells as measured by flow cytometry.

Authors:  H D Preisler; A Raza
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  Remission-induction regimens in acute nonlymphocytic leukemia.

Authors:  D C Brennan; J P Lewis
Journal:  West J Med       Date:  1980-10

7.  A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.

Authors:  D R Gandara; C A Ries; S A Schiff; C B George; J P Lewis; M M Koretz; S K Carter
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.